Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Purpose & Ideals
An Accord for a Healthier World: Working Together to Help Address Unmet Healthcare Needs in Lower-Income Countries
Currently, regulatory agencies may take up to seven years to approve essential medicines and vaccines in low- and middle-income counties (LMICs) from the time those same treatments were first approved in high-income countries, if they are approved at all.1 The burden remains disproportionately higher in low-income countries.2 Lack of access to quality healthcare is related to healthcare inequities in LMICs and hinders equitable access to safe and effective treatments.2Those living in LMICs...
Science & Innovation
In Celebrating 175 Years, Pfizer Challenges Itself to ‘Outdo Yesterday’
Image caption: Site of the Pfizer World Headquarters Building as it Appeared in 1861It started with a breakthrough.The year was 1849, and people everywhere were getting sick to their stomachs. In the days before widespread refrigeration, a simple meal of meat and potatoes could cause intestinal worms. A drug called santonin could kill the parasites, but it tasted so bitter many people avoided it.Charles Pfizer and his cousin, Charles Erhart, had just immigrated to the U.S. from Germany and...
Programs & Initiatives
Pfizer's Multicultural Health Equity Collective Marks 10 Years of Progress
Marginalized communities in the United States have faced generations of health inequities due to systemic discrimination embedded into our healthcare system. Life expectancy in the U.S., for instance, masks significant racial and ethnic disparities – the average life expectancy for non-Hispanic American Indians or Alaska Natives is seven years lower than it is for non-Hispanic whites.1
Real People
Advocacy, Strength, and Hope in the Face of Metastatic Melanoma: Bruce and Chris's Story
In 2013, Bruce’s life changed. He was living in sunny Florida with Chris, his wife of over 20 years, when he received an unexpected diagnosis: metastatic melanoma—the most aggressive form of skin cancer.1,2It was a disease Bruce had heard of before—a disease that will impact over 100,000 people in the U.S. this year and 510,000 people across the world by 2040.2,3 But it didn’t cross his mind when he noticed a small lesion on the top of his foot. Chris encouraged Bruce to get it checked out. In...
Trusted Voices
Together We Can Change the Odds for People with Cancer
One in three people in the United States will receive a cancer diagnosis in their lifetime.i This means you, or someone you know, may someday be impacted. This disease does not discriminate. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support. To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new three-year initiative, “Change the Odds: Uniting to Improve Cancer Outcomes,” aimed at addressing...
Real People
Got Yours? Spokesperson Martha Stewart on Health and Wellness
Martha Stewart has seemingly done it all – she’s a lifestyle expert, media mogul, and even founded a care center to support the geriatric population.She recently chatted with Pfizer.com about why she joined the Got Yours? COVID-19 vaccination campaign, how her father’s job at Pfizer impacted her view on science, how she juggles her busy schedule and more!Pfizer: The first thing we wanted to ask you is why you chose to partner with Pfizer, and if you've had a favorite part of being involved in...
Living & Wellbeing
Severe COVID-19 and the Continuing Importance of Protecting High Risk Populations
The concept of "severe COVID-19" can be a frightening one, especially when the term itself is so often misunderstood or confused with having self-assessed severe symptoms of COVID-19.Approximately 80% of those who test positive for COVID-19 have mild to moderate illness.1 But adults 50 and older and people of any age with certain underlying health conditions are at high risk of progression to severe COVID-19. That adds up to two in five people worldwide who are at increased risk for severe COVID...
Programs & Initiatives
The Future of Pharmacovigilance: Monitoring Medicine and Vaccine Safety Using AI and Other Tech
While many Pfizer colleagues worked to, develop and manufacture a vaccine for COVID-19, one Pfizer team was hard at work monitoring the safety of the COVID-19 vaccine trial. And they did so while also maintaining safety monitoring operations for more than 1,000 other products in the Pfizer portfolio.Pharmacovigilance is the name for the area of science which scientists and medical professionals monitor medicine and vaccine-related safety issues. “Medicine and vaccine safety is one of those...
Programs & Initiatives
The Importance of Returning Clinical Trial Data to Participants
Clinical trial participants are at the heart of medical research, and it’s with their help that Pfizer is able to bring life-changing treatments to patients.But, until recently, clinical trial sponsors like Pfizer have not been equipped to provide participants with their own personal clinical trial data when a trial ends. Pfizer’s team of clinical trial experts have worked for many years to change that by launching the Clinical Trial Participant Data Return Initiative.This first-of-its-kind...
Science & Innovation
Mathematical Sandbox: How Quantitative Systems Pharmacology Steers Safer, Faster Drug Development
Fear and anxiety swirled when Dr. Cynthia J. Musante’s husband contracted COVID-19. He faced a greater risk of coming down with a severe case since he was already unwell.But all their worries vanished in just 24 hours.Dr. Musante recalls that her husband soon started to feel better after being prescribed an investigational oral treatment for those with COVID-19. “It felt like a miracle,” he said. “I had felt so horrible.”As relief settled in, Dr. Musante felt something else: pride.After all...
Science & Innovation
From Math to Medicine: What Are Mathematical Models and How Do They Predict Pharmacology?
It sounds strange, but predicting how medications impact diseases and the body is a lot like forecasting the weather.To understand why, imagine opening a weather app on your smartphone to check the forecast for the upcoming weekend. You see that it’ll be sunny, 72 degrees, with a slight breeze—perfect weather. But how did scientists predict those precise physical conditions so far in the future?The answer: mathematical models.Scientists across disciplines use mathematical models to make...
Purpose & Ideals
Cancer Survivors' 'Butterfly Club' Network Fosters Support and Partnership
For many cancer survivors, life splits into two stages: before cancer and after cancer. That’s been the case for Lynette Bojko, Pfizer’s Head of Strategic Sourcing & Business Management. She was diagnosed with breast cancer just before her 40th birthday. “Unfortunately or fortunately, cancer is a lot of my identity,” she says. When treatment began, she didn’t want to hide what she was going through at the office, so she talked about it. That openness allowed her to connect with colleagues who...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.